MDMA/PTSD Jordan Study (Rejected)

MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder (PTSD)

Category: MDMA-Assisted Psychotherapy for PTSD: MAPS-Sponsored Clinical Trials

Principal Investigator: Nasser Shuriquie, M.D. and TBD
Location: Amman, Jordan

This study has been rejected by the Jordanian Food and Drug Administration (JFDA). MAPS will work with researchers to obtain government approval for this study when we begin planning for Phase 3 of our MDMA-assisted psychotherapy for PTSD development program. We hope to enroll Iraqi refugees living in Jordan who have PTSD, along with other Jordanians suffering from PTSD.

View the timeline for this study.